Materia Medica Holding
Clinical trials sponsored by Materia Medica Holding, explained in plain language.
-
New cold remedy for kids enters final testing phase
Symptom relief Recruiting nowThis study is testing if a medicine called Raphamin can help children aged 3-12 years recover faster from common colds and other viral respiratory infections. Researchers will compare Raphamin against a placebo (a dummy pill) to see if it safely reduces the time kids feel sick. T…
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated Apr 03, 2026 14:49 UTC
-
New cough syrup tested on tots during cold season
Symptom relief Recruiting nowThis study aims to see if a liquid medicine called Rengalin helps reduce cough in young children with common viral upper respiratory infections like colds or flu. Researchers will compare Rengalin to a placebo (a liquid with no medicine) in 264 children aged 6 months to 3 years. …
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC
-
New drug trial aims to clear up sinus misery faster
Symptom relief Recruiting nowThis study is testing if a drug called Raphamin can help adults with a sudden sinus infection (acute rhinosinusitis) get better more quickly. About 550 participants will take either Raphamin or a placebo (a pill with no medicine) for 5 days to see which group recovers faster. The…
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated Apr 03, 2026 14:43 UTC